Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,458 | 16,507 | 25,931 | 36,478 | 28,982 |
| Marketable Securities | 53,802 | 46,365 | 58,034 | 66,118 | 27,068 |
| Receivables | 8,452 | 13,433 | 8,897 | 9,525 | 10,441 |
| Inventories | 25,930 | 23,065 | 18,201 | 17,266 | 15,348 |
| TOTAL | $115,699 | $101,619 | $113,611 | $132,932 | $88,340 |
| Non-Current Assets | |||||
| PPE Net | 36,704 | 37,920 | 39,605 | 40,289 | 42,449 |
| Other Non-Current Assets | 4,546 | 4,545 | 4,688 | 4,684 | 4,719 |
| TOTAL | $41,250 | $42,465 | $44,293 | $44,973 | $47,168 |
| Total Assets | $156,949 | $144,084 | $157,904 | $177,905 | $135,508 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,567 | 9,093 | 8,574 | 6,514 | 8,221 |
| Accrued Expenses | 10,243 | 12,618 | 11,232 | 17,840 | 17,246 |
| Other current liabilities | 145 | 605 | 1,428 | 1,915 | 167 |
| TOTAL | $24,948 | $28,635 | $30,292 | $35,694 | $35,440 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,872 | 13,635 | 10,456 | 10,441 | 13,302 |
| Deferred Revenues | 5,993 | 6,319 | 6,151 | 6,782 | 6,683 |
| Other Non-Current Liabilities | 14,297 | 14,636 | 170 | 14,614 | 16,097 |
| TOTAL | $29,263 | $29,346 | $26,204 | $26,351 | $30,883 |
| Total Liabilities | $54,211 | $57,981 | $56,496 | $62,045 | $66,323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,877 | 130,694 | 116,250 | 115,592 | 93,551 |
| Common Shares | 132 | 116 | 116 | 116 | 94 |
| Retained earnings | -903,723 | -879,733 | -858,971 | -836,950 | -811,411 |
| Other shareholders' equity | -38 | -32 | -2 | -16 | -3 |
| TOTAL | $102,738 | $86,103 | $101,408 | $115,860 | $69,185 |
| Total Liabilities And Equity | $156,949 | $144,084 | $157,904 | $177,905 | $135,508 |